TABLE 2.
Cell surface expression of activation markers on distinct immune cell subsets at baseline and after 28 days of overfeeding in a subset of 24 subjects
| Activation marker (relative mean fluorescence intensity) | Day 0 | Day 28 | P |
|---|---|---|---|
| Neutrophils CD66b | 7.5 ± 0.7 | 7.9 ± 0.8 | 0.68 |
| Neutrophils CD62L | 41.4 ± 5.6 | 42.3 ± 6.6 | 0.21 |
| Neutrophils CD11b | 1.8 ± 0.2 | 2.1 ± 0.5 | 0.40 |
| Monocytes CD66b | 0.9 ± 0.0 | 1.0 ± 0.0 | 0.21 |
| Monocytes CD62L | 55.2 ± 11.9 | 61.9 ± 10.4 | 0.99 |
| Monocytes CD11b | 6.9 ± 0.9 | 6.0 ± 1.4 | 0.10 |
| T-cells CD69 | 1.1 ± 0.1 | 1.0 ± 0.0 | 0.68 |
| T-cells CD62L | 30.0 ± 5.7 | 35.5 ± 6.2 | 0.99 |
| T-cells CD25 | 1.5 ± 0.3 | 1.2 ± 0.1 | 0.83 |
Data are presented as means ± SE. Degranulation marker CD66b, adhesion molecule CD62L, adhesion molecule CD11b, interleukin-2 receptor (CD25), activation marker CD69, and adhesion molecule CD62L.